Secret US-UK talks on drug pricing revealed

Despite the UK still not leaving the European Union – pencilled in for the 31 January 2020 at the time of writing – the need to strike new trade deals has led to secret trade discussions be

Measuring value to ensure access in divisive times

Globally, balancing rising healthcare costs with the drive for innovation is a political hot potato – is a greater focus on patient-reported data the centre of value-based gravity we’ve bee

California is first US state to ban pay-for-delay deals

Medicare coverage for CAR-T drugs on the horizon

Medicare could soon cover CAR-T therapies under new proposals from the US’ Centers for Medicare & Medicaid Services (CMS), which aim to also gather real-world evidence to eventually inf

Democrats escalate US war on drug pricing

It was the newly-empowered Democrats’ turn to take on pharma drug pricing in the US this week, as senator Bernie Sanders and representative Elijah Cummings introduced legislation to curb fu